avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.15 | Hnf4g |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf4g | mm39_v1_chr3_+_3699205_3699221 | -0.27 | 1.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_39275518 | 25.20 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr17_-_46749370 | 20.19 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr9_-_46146558 | 18.79 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr2_+_172994841 | 18.59 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr16_+_22738987 | 15.95 |
ENSMUST00000023587.12
|
Fetub
|
fetuin beta |
chr7_-_105249308 | 12.89 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr11_+_69945157 | 12.26 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr19_-_40062174 | 12.23 |
ENSMUST00000048959.5
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr19_+_39980868 | 12.21 |
ENSMUST00000049178.3
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr16_+_22739191 | 12.13 |
ENSMUST00000116625.10
|
Fetub
|
fetuin beta |
chr9_-_46146928 | 12.06 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr11_+_16702203 | 11.85 |
ENSMUST00000102884.10
ENSMUST00000020329.13 |
Egfr
|
epidermal growth factor receptor |
chr19_+_12610668 | 11.73 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chr15_-_82648376 | 11.48 |
ENSMUST00000055721.6
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr15_+_10224052 | 11.45 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr4_-_115353326 | 10.65 |
ENSMUST00000030487.3
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr8_+_105460627 | 10.60 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr11_-_5865124 | 10.54 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr9_-_48516447 | 10.35 |
ENSMUST00000034808.12
ENSMUST00000119426.2 |
Nnmt
|
nicotinamide N-methyltransferase |
chr19_-_39875192 | 10.24 |
ENSMUST00000168838.3
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr17_+_25097199 | 9.84 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr2_+_58645189 | 9.74 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr10_-_127724557 | 9.69 |
ENSMUST00000047199.5
|
Rdh7
|
retinol dehydrogenase 7 |
chr11_+_115353290 | 9.61 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr1_+_74752710 | 9.54 |
ENSMUST00000027356.7
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr16_+_26400454 | 9.51 |
ENSMUST00000096129.9
ENSMUST00000166294.9 ENSMUST00000174202.8 ENSMUST00000023156.13 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr1_-_121255448 | 9.50 |
ENSMUST00000186915.2
ENSMUST00000160968.8 ENSMUST00000162582.2 |
Insig2
|
insulin induced gene 2 |
chr9_-_121745354 | 9.40 |
ENSMUST00000062474.5
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr6_+_141575226 | 9.29 |
ENSMUST00000042812.9
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr10_-_24803336 | 9.26 |
ENSMUST00000020161.10
|
Arg1
|
arginase, liver |
chr15_+_82336535 | 9.20 |
ENSMUST00000089129.7
ENSMUST00000229313.2 ENSMUST00000231136.2 |
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr9_-_103165423 | 9.07 |
ENSMUST00000123530.8
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr9_-_57590926 | 8.90 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr13_-_55574582 | 8.88 |
ENSMUST00000170921.2
|
F12
|
coagulation factor XII (Hageman factor) |
chr13_-_55574596 | 8.86 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr7_+_26821266 | 8.80 |
ENSMUST00000206552.2
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr12_-_103739847 | 8.79 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr19_+_38995463 | 8.63 |
ENSMUST00000025966.5
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr19_+_4036562 | 8.55 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr10_+_127702326 | 8.48 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr4_-_62005498 | 8.40 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr10_+_127595639 | 8.37 |
ENSMUST00000128247.2
|
Rdh16f1
|
RDH16 family member 1 |
chr8_-_93806593 | 8.27 |
ENSMUST00000109582.3
|
Ces1b
|
carboxylesterase 1B |
chr8_+_13076024 | 8.12 |
ENSMUST00000033820.4
|
F7
|
coagulation factor VII |
chr7_+_13467422 | 8.08 |
ENSMUST00000086148.8
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr10_+_18720760 | 8.03 |
ENSMUST00000019998.9
|
Perp
|
PERP, TP53 apoptosis effector |
chr19_+_12610870 | 7.97 |
ENSMUST00000119960.2
|
Glyat
|
glycine-N-acyltransferase |
chr2_-_25390625 | 7.87 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr17_+_35482063 | 7.68 |
ENSMUST00000172503.3
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr11_-_75313350 | 7.60 |
ENSMUST00000125982.2
ENSMUST00000137103.8 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr9_+_46179899 | 7.58 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr1_-_162812087 | 7.39 |
ENSMUST00000028010.9
|
Fmo3
|
flavin containing monooxygenase 3 |
chr3_-_113367891 | 7.37 |
ENSMUST00000142505.9
|
Amy1
|
amylase 1, salivary |
chr16_-_17906886 | 7.36 |
ENSMUST00000132241.2
ENSMUST00000139861.2 ENSMUST00000003620.13 |
Prodh
|
proline dehydrogenase |
chr9_+_46151994 | 7.25 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chrX_+_138701544 | 7.23 |
ENSMUST00000054889.4
|
Cldn2
|
claudin 2 |
chr17_-_35081129 | 7.20 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr17_-_35081456 | 7.11 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr7_-_12732067 | 7.04 |
ENSMUST00000032539.14
ENSMUST00000120903.8 |
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr19_-_40175709 | 7.03 |
ENSMUST00000051846.13
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr10_+_127637015 | 7.00 |
ENSMUST00000071646.2
|
Rdh16
|
retinol dehydrogenase 16 |
chr12_-_103704417 | 6.95 |
ENSMUST00000095450.11
ENSMUST00000187220.2 |
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr1_+_171041539 | 6.95 |
ENSMUST00000005820.11
ENSMUST00000075469.12 ENSMUST00000155126.8 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr4_+_20008357 | 6.95 |
ENSMUST00000117632.8
ENSMUST00000098244.2 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr4_+_141473983 | 6.94 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr13_-_93774469 | 6.92 |
ENSMUST00000099309.6
|
Bhmt
|
betaine-homocysteine methyltransferase |
chr7_+_143027473 | 6.86 |
ENSMUST00000052348.12
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr8_-_95422851 | 6.83 |
ENSMUST00000034227.6
|
Pllp
|
plasma membrane proteolipid |
chr8_-_123962937 | 6.80 |
ENSMUST00000098327.2
ENSMUST00000212818.2 ENSMUST00000166768.3 |
Spata2l
|
spermatogenesis associated 2-like |
chr3_-_121608809 | 6.74 |
ENSMUST00000197383.5
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr16_+_22739028 | 6.74 |
ENSMUST00000232097.2
|
Fetub
|
fetuin beta |
chr11_-_115078147 | 6.70 |
ENSMUST00000103038.8
ENSMUST00000103039.2 ENSMUST00000103040.11 |
Nat9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr4_-_107975701 | 6.69 |
ENSMUST00000149106.8
|
Scp2
|
sterol carrier protein 2, liver |
chr2_+_102536701 | 6.62 |
ENSMUST00000123759.8
ENSMUST00000005220.11 ENSMUST00000111212.8 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_-_127206300 | 6.61 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr16_-_18232202 | 6.61 |
ENSMUST00000165430.8
ENSMUST00000147720.3 |
Comt
|
catechol-O-methyltransferase |
chr12_-_103829810 | 6.61 |
ENSMUST00000085056.8
ENSMUST00000072876.12 ENSMUST00000124717.2 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr4_+_63262775 | 6.57 |
ENSMUST00000030044.3
|
Orm1
|
orosomucoid 1 |
chr1_-_180023467 | 6.54 |
ENSMUST00000161746.2
ENSMUST00000160879.7 |
Coq8a
|
coenzyme Q8A |
chr8_-_93956143 | 6.51 |
ENSMUST00000176282.2
ENSMUST00000034173.14 |
Ces1e
|
carboxylesterase 1E |
chr9_-_103165489 | 6.48 |
ENSMUST00000035163.10
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr9_+_108174052 | 6.47 |
ENSMUST00000035230.7
|
Amt
|
aminomethyltransferase |
chr2_-_25391729 | 6.39 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr1_-_180023518 | 6.38 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr17_-_46749320 | 6.36 |
ENSMUST00000233575.2
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr1_+_171041583 | 6.34 |
ENSMUST00000111328.8
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr10_+_127612243 | 6.32 |
ENSMUST00000136223.2
ENSMUST00000052652.7 |
Rdh9
|
retinol dehydrogenase 9 |
chr3_-_113368407 | 6.28 |
ENSMUST00000106540.8
|
Amy1
|
amylase 1, salivary |
chr11_-_59927688 | 6.26 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr3_-_121608859 | 6.26 |
ENSMUST00000029770.8
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr1_-_91340884 | 6.25 |
ENSMUST00000086851.2
|
Hes6
|
hairy and enhancer of split 6 |
chrX_+_59044796 | 6.20 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr11_-_5900019 | 6.17 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr8_-_41668182 | 6.17 |
ENSMUST00000034003.5
|
Fgl1
|
fibrinogen-like protein 1 |
chr4_-_96441854 | 6.15 |
ENSMUST00000030303.6
|
Cyp2j6
|
cytochrome P450, family 2, subfamily j, polypeptide 6 |
chr17_-_34962823 | 6.14 |
ENSMUST00000069507.9
|
C4b
|
complement component 4B (Chido blood group) |
chr9_+_106324952 | 6.10 |
ENSMUST00000215475.2
ENSMUST00000187106.7 ENSMUST00000190167.7 |
Abhd14b
|
abhydrolase domain containing 14b |
chr7_-_139682280 | 6.06 |
ENSMUST00000142105.8
|
Fuom
|
fucose mutarotase |
chr6_+_124470053 | 5.82 |
ENSMUST00000049124.10
|
C1rl
|
complement component 1, r subcomponent-like |
chr9_-_118986123 | 5.73 |
ENSMUST00000010795.5
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr17_+_32904601 | 5.71 |
ENSMUST00000168171.8
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr3_-_157630690 | 5.69 |
ENSMUST00000118539.2
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr19_-_39637489 | 5.56 |
ENSMUST00000067328.7
|
Cyp2c67
|
cytochrome P450, family 2, subfamily c, polypeptide 67 |
chr11_+_120382666 | 5.48 |
ENSMUST00000026899.4
|
Slc25a10
|
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 |
chr4_+_63280675 | 5.44 |
ENSMUST00000075341.4
|
Orm2
|
orosomucoid 2 |
chr2_+_32498997 | 5.44 |
ENSMUST00000143625.2
ENSMUST00000128811.2 |
St6galnac6
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
chr5_+_127709302 | 5.43 |
ENSMUST00000118139.3
|
Glt1d1
|
glycosyltransferase 1 domain containing 1 |
chr7_+_13357892 | 5.42 |
ENSMUST00000108525.4
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr8_+_13087805 | 5.41 |
ENSMUST00000128418.8
ENSMUST00000152034.2 |
F10
|
coagulation factor X |
chr10_+_40505985 | 5.39 |
ENSMUST00000019977.8
ENSMUST00000214102.2 ENSMUST00000213503.2 ENSMUST00000213442.2 ENSMUST00000216830.2 |
Ddo
|
D-aspartate oxidase |
chr7_-_126275529 | 5.34 |
ENSMUST00000106372.11
ENSMUST00000155419.3 ENSMUST00000106373.9 |
Sult1a1
|
sulfotransferase family 1A, phenol-preferring, member 1 |
chr7_-_99345016 | 5.32 |
ENSMUST00000107086.9
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr17_+_35658131 | 5.30 |
ENSMUST00000071951.14
ENSMUST00000116598.10 ENSMUST00000078205.14 ENSMUST00000076256.8 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr17_+_25798059 | 5.30 |
ENSMUST00000141606.3
ENSMUST00000063344.15 ENSMUST00000116641.9 |
Lmf1
|
lipase maturation factor 1 |
chr16_+_37400590 | 5.26 |
ENSMUST00000159787.8
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr11_-_59937302 | 5.23 |
ENSMUST00000000310.14
ENSMUST00000102693.9 ENSMUST00000148512.2 |
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr17_+_27236961 | 5.22 |
ENSMUST00000142141.3
ENSMUST00000122106.9 |
Ggnbp1
|
gametogenetin binding protein 1 |
chr15_+_31565508 | 5.22 |
ENSMUST00000226951.2
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr1_+_133291302 | 5.20 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr4_-_61592331 | 5.18 |
ENSMUST00000098040.4
|
Mup18
|
major urinary protein 18 |
chr12_-_103871146 | 5.18 |
ENSMUST00000074051.6
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr16_-_21606546 | 5.16 |
ENSMUST00000023559.7
|
Ehhadh
|
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
chr8_-_25066313 | 5.14 |
ENSMUST00000121992.2
|
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr2_-_91466739 | 5.14 |
ENSMUST00000111335.2
ENSMUST00000028681.15 |
F2
|
coagulation factor II |
chr16_+_37400500 | 5.13 |
ENSMUST00000160847.2
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr9_-_65330231 | 5.11 |
ENSMUST00000065894.7
|
Slc51b
|
solute carrier family 51, beta subunit |
chr11_+_73090270 | 5.09 |
ENSMUST00000006105.7
|
Shpk
|
sedoheptulokinase |
chr1_+_88034556 | 5.08 |
ENSMUST00000113137.2
|
Ugt1a6b
|
UDP glucuronosyltransferase 1 family, polypeptide A6B |
chr2_-_25351024 | 5.07 |
ENSMUST00000151239.2
|
Paxx
|
non-homologous end joining factor |
chr17_+_32904629 | 5.05 |
ENSMUST00000008801.7
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr10_+_23727325 | 5.03 |
ENSMUST00000020190.8
|
Vnn3
|
vanin 3 |
chr7_-_30672747 | 4.98 |
ENSMUST00000205961.2
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr9_-_103105638 | 4.96 |
ENSMUST00000126359.2
|
Trf
|
transferrin |
chr16_+_22710785 | 4.93 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr13_-_42001075 | 4.93 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr18_-_38345010 | 4.90 |
ENSMUST00000159405.3
ENSMUST00000160721.8 |
Pcdh1
|
protocadherin 1 |
chr9_+_37466989 | 4.89 |
ENSMUST00000213126.2
|
Siae
|
sialic acid acetylesterase |
chr15_-_76191301 | 4.87 |
ENSMUST00000171340.9
ENSMUST00000023222.13 ENSMUST00000164189.2 |
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr10_+_62860291 | 4.85 |
ENSMUST00000020262.5
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr2_-_27138347 | 4.81 |
ENSMUST00000139312.8
|
Sardh
|
sarcosine dehydrogenase |
chr10_-_41366321 | 4.80 |
ENSMUST00000019965.13
|
Smpd2
|
sphingomyelin phosphodiesterase 2, neutral |
chr7_-_30672824 | 4.78 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr5_-_89583469 | 4.76 |
ENSMUST00000200534.2
|
Gc
|
vitamin D binding protein |
chr7_-_30672889 | 4.68 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr16_+_22713593 | 4.63 |
ENSMUST00000232674.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr19_+_34268053 | 4.58 |
ENSMUST00000025691.13
|
Fas
|
Fas (TNF receptor superfamily member 6) |
chr12_-_81014849 | 4.56 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr12_-_103796632 | 4.54 |
ENSMUST00000164454.3
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr7_-_97228589 | 4.50 |
ENSMUST00000151840.2
ENSMUST00000135998.8 ENSMUST00000144858.8 ENSMUST00000146605.8 ENSMUST00000072725.12 ENSMUST00000138060.3 ENSMUST00000154853.8 ENSMUST00000136757.8 ENSMUST00000124552.3 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr10_+_62860094 | 4.49 |
ENSMUST00000124784.8
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr13_-_42001102 | 4.49 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr6_+_71176811 | 4.48 |
ENSMUST00000067492.8
|
Fabp1
|
fatty acid binding protein 1, liver |
chr12_-_81014755 | 4.45 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr2_+_58644922 | 4.44 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr8_-_3517617 | 4.42 |
ENSMUST00000111081.10
ENSMUST00000004686.13 |
Pex11g
|
peroxisomal biogenesis factor 11 gamma |
chr13_-_42000958 | 4.42 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr7_+_100970435 | 4.38 |
ENSMUST00000210192.2
ENSMUST00000172630.8 |
Stard10
|
START domain containing 10 |
chr2_-_134396268 | 4.33 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr7_-_121666486 | 4.31 |
ENSMUST00000033159.4
|
Ears2
|
glutamyl-tRNA synthetase 2, mitochondrial |
chr2_-_62242562 | 4.30 |
ENSMUST00000047812.8
|
Dpp4
|
dipeptidylpeptidase 4 |
chr15_+_31572251 | 4.30 |
ENSMUST00000161088.3
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr14_-_30645711 | 4.27 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr9_-_44710480 | 4.27 |
ENSMUST00000214833.2
ENSMUST00000213972.2 ENSMUST00000214431.2 ENSMUST00000213363.2 ENSMUST00000114705.9 ENSMUST00000002100.8 |
Tmem25
|
transmembrane protein 25 |
chr4_+_45848918 | 4.27 |
ENSMUST00000030011.6
|
Stra6l
|
STRA6-like |
chr4_+_45848816 | 4.19 |
ENSMUST00000107782.8
|
Stra6l
|
STRA6-like |
chr6_-_146403638 | 4.19 |
ENSMUST00000079573.13
|
Itpr2
|
inositol 1,4,5-triphosphate receptor 2 |
chr5_-_113229445 | 4.17 |
ENSMUST00000131708.2
ENSMUST00000117143.8 ENSMUST00000119627.8 |
Crybb3
|
crystallin, beta B3 |
chr7_+_44114815 | 4.16 |
ENSMUST00000035929.11
ENSMUST00000146128.8 |
Aspdh
|
aspartate dehydrogenase domain containing |
chr5_+_137568113 | 4.15 |
ENSMUST00000031729.13
ENSMUST00000199054.5 |
Tfr2
|
transferrin receptor 2 |
chr15_-_78352801 | 4.14 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr11_+_69983531 | 4.05 |
ENSMUST00000124721.2
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr8_+_13087292 | 4.04 |
ENSMUST00000063820.12
ENSMUST00000033821.11 |
F10
|
coagulation factor X |
chr2_+_32489710 | 4.03 |
ENSMUST00000131229.8
ENSMUST00000140983.8 |
St6galnac6
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
chr11_-_94492688 | 4.03 |
ENSMUST00000103164.4
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr16_+_34842764 | 4.02 |
ENSMUST00000061156.10
|
Hacd2
|
3-hydroxyacyl-CoA dehydratase 2 |
chr13_+_24054241 | 4.01 |
ENSMUST00000110413.8
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr17_-_56424265 | 4.01 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr8_-_4155758 | 4.00 |
ENSMUST00000138439.2
ENSMUST00000145007.8 |
Cd209f
|
CD209f antigen |
chr19_+_34268071 | 4.00 |
ENSMUST00000112472.4
ENSMUST00000235232.2 |
Fas
|
Fas (TNF receptor superfamily member 6) |
chr1_+_160806241 | 3.98 |
ENSMUST00000195760.2
|
Serpinc1
|
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
chr1_+_93062962 | 3.97 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr1_+_75187474 | 3.97 |
ENSMUST00000027401.11
ENSMUST00000144355.8 ENSMUST00000123825.8 ENSMUST00000189698.7 |
Stk16
|
serine/threonine kinase 16 |
chr11_+_53348032 | 3.97 |
ENSMUST00000109013.9
ENSMUST00000018531.12 ENSMUST00000093114.5 |
Shroom1
|
shroom family member 1 |
chr11_+_69983479 | 3.96 |
ENSMUST00000143772.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr5_+_31079177 | 3.94 |
ENSMUST00000031053.15
ENSMUST00000202752.2 |
Khk
|
ketohexokinase |
chr17_+_56469477 | 3.92 |
ENSMUST00000077788.7
|
Tnfaip8l1
|
tumor necrosis factor, alpha-induced protein 8-like 1 |
chr7_+_44114857 | 3.91 |
ENSMUST00000135624.2
|
Aspdh
|
aspartate dehydrogenase domain containing |
chr4_+_134124691 | 3.89 |
ENSMUST00000105870.8
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr7_+_140415431 | 3.88 |
ENSMUST00000209978.2
ENSMUST00000210916.2 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr16_+_22710134 | 3.82 |
ENSMUST00000231328.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr15_-_82291372 | 3.81 |
ENSMUST00000230198.2
ENSMUST00000230248.2 ENSMUST00000072776.5 ENSMUST00000229911.2 |
Cyp2d10
|
cytochrome P450, family 2, subfamily d, polypeptide 10 |
chr13_-_41373638 | 3.80 |
ENSMUST00000117096.2
|
Elovl2
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 |
chr17_-_56312555 | 3.77 |
ENSMUST00000043785.8
|
Stap2
|
signal transducing adaptor family member 2 |
chr18_+_21094477 | 3.75 |
ENSMUST00000234316.2
|
Rnf125
|
ring finger protein 125 |
chr19_-_44017637 | 3.74 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr6_-_83633064 | 3.74 |
ENSMUST00000014686.3
|
Clec4f
|
C-type lectin domain family 4, member f |
chr7_-_126497421 | 3.73 |
ENSMUST00000121532.8
ENSMUST00000032926.12 |
Tmem219
|
transmembrane protein 219 |
chr1_-_121255400 | 3.72 |
ENSMUST00000159085.8
ENSMUST00000159125.2 ENSMUST00000161818.2 |
Insig2
|
insulin induced gene 2 |
chr7_+_37882642 | 3.69 |
ENSMUST00000178207.10
ENSMUST00000179525.10 |
1600014C10Rik
|
RIKEN cDNA 1600014C10 gene |
chr19_-_8382424 | 3.67 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 30.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.9 | 17.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
4.8 | 14.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
4.6 | 18.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.4 | 13.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
3.3 | 16.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.1 | 9.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.9 | 8.8 | GO:0090420 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
2.9 | 8.6 | GO:0031104 | dendrite regeneration(GO:0031104) |
2.8 | 8.5 | GO:0071938 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
2.8 | 86.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.7 | 5.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.5 | 7.6 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
2.5 | 9.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.4 | 4.9 | GO:1902958 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
2.4 | 7.3 | GO:0044240 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
2.3 | 13.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.3 | 9.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
2.3 | 6.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.3 | 16.2 | GO:0015886 | heme transport(GO:0015886) |
2.2 | 8.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.2 | 10.9 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
2.2 | 6.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.0 | 34.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.0 | 14.2 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
2.0 | 5.9 | GO:0043387 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) |
2.0 | 11.8 | GO:0070459 | prolactin secretion(GO:0070459) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.9 | 7.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.8 | 7.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.7 | 7.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.7 | 5.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.7 | 5.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.7 | 5.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.7 | 6.7 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
1.7 | 13.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.7 | 6.6 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.6 | 11.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.6 | 4.8 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.6 | 44.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.6 | 6.2 | GO:0015744 | succinate transport(GO:0015744) |
1.5 | 4.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.5 | 7.7 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.5 | 7.7 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.5 | 4.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 4.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
1.4 | 14.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.4 | 40.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.4 | 12.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 14.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.3 | 5.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.2 | 13.7 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.2 | 9.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.2 | 3.6 | GO:0006530 | asparagine catabolic process(GO:0006530) |
1.2 | 2.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.2 | 3.5 | GO:0090320 | regulation of chylomicron remnant clearance(GO:0090320) |
1.2 | 4.6 | GO:0046226 | coumarin metabolic process(GO:0009804) coumarin catabolic process(GO:0046226) |
1.2 | 10.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.1 | 3.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.1 | 3.4 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
1.1 | 5.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.1 | 3.3 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
1.1 | 3.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.0 | 5.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.0 | 3.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.0 | 11.9 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
1.0 | 3.9 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.0 | 11.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
1.0 | 2.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.0 | 2.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 6.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 2.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.9 | 0.9 | GO:0061744 | motor behavior(GO:0061744) |
0.9 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 10.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 10.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 1.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.9 | 2.6 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
0.9 | 4.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.8 | 2.5 | GO:0002414 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 3.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.8 | 14.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.8 | 2.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.8 | 4.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 1.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.8 | 4.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.8 | 3.2 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 3.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.8 | 2.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.8 | 5.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.7 | 9.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 42.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.7 | 2.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 17.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 6.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.7 | 2.0 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.7 | 4.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.7 | 15.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 2.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.7 | 7.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 6.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 24.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 1.9 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.6 | 3.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.6 | 4.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.6 | 9.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.6 | 1.8 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.6 | 1.8 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.6 | 4.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.6 | 2.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.6 | 1.7 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.6 | 1.7 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) negative regulation of myofibroblast differentiation(GO:1904761) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.6 | 1.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.6 | 1.7 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
0.6 | 7.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 30.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.6 | 6.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 7.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 2.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 3.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 2.1 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.5 | 4.8 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 5.8 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.5 | 2.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.5 | 1.1 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.5 | 6.2 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 2.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 3.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 2.9 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.5 | 1.9 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.5 | 4.9 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 3.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 2.9 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.5 | 1.4 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.5 | 2.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 3.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 1.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.5 | 1.8 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 1.4 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 3.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 1.4 | GO:1904793 | regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.4 | 1.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 1.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 4.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.4 | 2.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 3.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 1.6 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 2.8 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.4 | 4.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 2.0 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.4 | 1.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 5.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.4 | 1.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 9.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 1.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.4 | 1.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.4 | 1.4 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 2.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.4 | 1.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.4 | 1.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.4 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 5.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.4 | 1.1 | GO:0060540 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
0.3 | 8.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 1.7 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 1.0 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.3 | 7.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 4.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.3 | 3.7 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.7 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.3 | 3.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.3 | 1.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.0 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) |
0.3 | 1.0 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.3 | 1.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.3 | 4.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 0.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.8 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 4.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 3.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 2.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 3.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 0.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.9 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.3 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 2.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.3 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.3 | 3.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 3.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.9 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 0.9 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 2.0 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.3 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.1 | GO:0050823 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.3 | 3.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 2.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 1.1 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 5.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 1.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.8 | GO:1902659 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.3 | 3.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.3 | 1.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 12.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 10.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 2.4 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.3 | 1.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 1.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 2.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 2.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 2.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 4.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.3 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 4.1 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 1.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 0.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.2 | 1.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 2.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.8 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 4.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 1.6 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.2 | 2.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.6 | GO:1901162 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 1.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.2 | 9.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 4.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 3.7 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 3.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 4.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 4.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.6 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.4 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 5.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 1.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.9 | GO:0036493 | positive regulation of translational initiation in response to stress(GO:0032058) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 1.8 | GO:0006901 | vesicle coating(GO:0006901) |
0.2 | 0.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 1.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 1.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 1.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.5 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.2 | 0.5 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.2 | 3.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.3 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.2 | 4.7 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 3.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.2 | 2.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.9 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 0.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.6 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.2 | 1.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 5.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 4.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 3.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.8 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.4 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 6.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 1.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 2.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 2.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.8 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 2.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 2.1 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 4.2 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 2.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.8 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 3.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 2.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 2.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.2 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 10.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:2000724 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.1 | 1.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.7 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 3.3 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.4 | GO:0070781 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 6.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 2.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.3 | GO:1900063 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) regulation of peroxisome organization(GO:1900063) |
0.1 | 2.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 2.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.2 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.1 | 0.3 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.1 | 1.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 1.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.4 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.1 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 1.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 1.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 1.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 2.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.5 | GO:0060708 | negative regulation of Schwann cell proliferation(GO:0010626) spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0060112 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.5 | GO:0051001 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 4.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.2 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.1 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 1.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.4 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 1.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.7 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 7.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.7 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 3.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 3.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 1.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.6 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 2.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.5 | GO:1902590 | viral budding via host ESCRT complex(GO:0039702) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 2.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0090366 | DNA cytosine deamination(GO:0070383) positive regulation of mRNA modification(GO:0090366) |
0.1 | 0.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.6 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 1.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 2.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 1.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 1.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.0 | 1.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 1.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 1.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.1 | GO:0033685 | regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.8 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 1.9 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.0 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 4.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 1.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.4 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.5 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 8.6 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.0 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.9 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 5.2 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.4 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
0.0 | 0.1 | GO:0017126 | nucleologenesis(GO:0017126) |
0.0 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 3.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 2.5 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 1.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 1.0 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 1.8 | GO:0030258 | lipid modification(GO:0030258) |
0.0 | 0.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.0 | 0.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.3 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.7 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 2.6 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 2.4 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.7 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 3.5 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 1.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 32.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.6 | 31.6 | GO:0042627 | chylomicron(GO:0042627) |
1.9 | 17.4 | GO:0005579 | membrane attack complex(GO:0005579) |
1.8 | 8.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.7 | 13.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.4 | 19.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.3 | 7.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.3 | 5.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.2 | 14.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.2 | 35.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.1 | 10.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 19.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 11.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 2.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.0 | 8.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 16.8 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 2.6 | GO:0005715 | late recombination nodule(GO:0005715) |
0.7 | 2.9 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.6 | 2.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 3.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 1.8 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.6 | 4.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 8.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 9.1 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 4.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 2.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 4.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 2.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 2.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 8.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 1.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.3 | 0.9 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.3 | 2.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 2.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 22.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 56.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 61.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 1.1 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 1.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 3.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 2.5 | GO:0000801 | central element(GO:0000801) |
0.2 | 7.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.9 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 0.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 2.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 2.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.1 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 5.4 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 6.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 9.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 5.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 2.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 1.2 | GO:0001652 | granular component(GO:0001652) senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 7.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 3.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 3.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 26.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 19.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 5.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 10.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 60.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 0.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 198.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 3.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.3 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 12.3 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.1 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 2.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 7.3 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.0 | 5.6 | GO:0044429 | mitochondrial part(GO:0044429) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 8.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 2.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 34.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 2.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 33.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.8 | 27.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
6.2 | 18.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
5.6 | 33.6 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
4.9 | 19.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.0 | 11.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.8 | 13.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.8 | 16.7 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
2.7 | 16.1 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 15.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.5 | 7.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
2.5 | 14.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.3 | 6.9 | GO:0008431 | vitamin E binding(GO:0008431) |
2.2 | 9.0 | GO:0042806 | fucose binding(GO:0042806) |
2.2 | 6.7 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.2 | 6.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
2.2 | 8.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.1 | 8.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.0 | 17.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
2.0 | 13.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.9 | 7.7 | GO:0005118 | sevenless binding(GO:0005118) |
1.7 | 5.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.7 | 5.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.7 | 54.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
1.7 | 5.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.7 | 6.7 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
1.7 | 16.7 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.6 | 4.8 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.6 | 6.4 | GO:0004103 | choline kinase activity(GO:0004103) |
1.6 | 7.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.6 | 6.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.5 | 7.7 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.5 | 32.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.4 | 5.8 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
1.4 | 31.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.4 | 15.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.4 | 7.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.3 | 5.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.3 | 4.0 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
1.3 | 3.9 | GO:0004454 | ketohexokinase activity(GO:0004454) |
1.3 | 51.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.3 | 3.9 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
1.3 | 14.2 | GO:0035473 | lipase binding(GO:0035473) |
1.3 | 3.8 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.3 | 7.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
1.2 | 3.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 3.6 | GO:0004067 | asparaginase activity(GO:0004067) |
1.2 | 13.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.2 | 3.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.2 | 4.6 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.2 | 19.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.1 | 3.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
1.1 | 4.5 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.1 | 3.4 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.1 | 27.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.1 | 3.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.1 | 6.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.1 | 3.3 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
1.1 | 8.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 6.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.1 | 5.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 5.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.1 | 13.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 11.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 4.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.0 | 8.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.0 | 20.5 | GO:0001848 | complement binding(GO:0001848) |
1.0 | 2.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.0 | 5.8 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 2.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.9 | 9.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 2.8 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.9 | 8.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 29.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.9 | 2.7 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.9 | 6.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.9 | 5.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 6.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 4.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 5.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 4.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.8 | 2.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.8 | 7.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 3.1 | GO:0019862 | IgA binding(GO:0019862) |
0.8 | 3.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.8 | 5.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.8 | 1.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.7 | 2.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.7 | 1.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 3.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 8.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.7 | 2.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.7 | 3.4 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.7 | 4.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.7 | 2.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.6 | 9.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 4.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.6 | 17.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.6 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 2.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 1.8 | GO:0035478 | chylomicron binding(GO:0035478) |
0.6 | 0.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.6 | 2.9 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.6 | 2.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 1.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 3.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 1.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 1.7 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.5 | 1.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.5 | 3.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 9.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.5 | 5.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 3.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 5.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 2.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 1.6 | GO:0034012 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.5 | 1.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 5.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 3.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.5 | 7.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 1.5 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.5 | 1.5 | GO:0070404 | NADH binding(GO:0070404) |
0.5 | 5.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 2.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.5 | 1.9 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 4.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 3.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 2.6 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 2.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 1.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 2.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 8.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 1.6 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.4 | 2.8 | GO:0050610 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.4 | 1.6 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.4 | 3.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 4.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.4 | 1.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.4 | 4.7 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 4.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.1 | GO:0071820 | N-box binding(GO:0071820) |
0.3 | 50.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 2.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 1.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.3 | 1.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 7.4 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 1.0 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.3 | 2.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.3 | 2.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 13.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 2.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.3 | 1.6 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 3.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 5.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 9.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 1.2 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 3.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 7.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 3.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 5.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 1.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.1 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.3 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 3.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.3 | 0.8 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.3 | 3.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 4.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 6.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 2.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 0.8 | GO:0016296 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
0.2 | 3.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 2.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 4.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 2.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 2.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 3.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 3.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 2.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.2 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 29.9 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 2.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 7.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 1.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 4.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 3.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.5 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.2 | 0.5 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.7 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.2 | 1.1 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 3.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 3.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 3.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 9.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 29.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.4 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.1 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 7.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 6.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 3.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.5 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 0.3 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 4.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.1 | 0.4 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 3.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 8.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) lipopeptide binding(GO:0071723) |
0.1 | 5.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 2.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0032405 | exodeoxyribonuclease III activity(GO:0008853) MutLalpha complex binding(GO:0032405) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 3.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.1 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 3.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 7.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 2.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 7.5 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 2.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 6.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 1.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.3 | GO:0004131 | cytosine deaminase activity(GO:0004131) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.2 | GO:0019809 | spermidine binding(GO:0019809) |
0.1 | 0.2 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 0.5 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 2.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 3.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 1.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 3.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 4.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.4 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 1.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 1.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 8.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 18.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 3.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 10.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 31.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 16.4 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 62.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 14.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 7.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 13.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 6.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 2.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 6.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.2 | 30.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.0 | 28.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.7 | 26.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.6 | 20.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.5 | 44.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.3 | 5.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 15.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.2 | 20.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.1 | 15.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 9.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.0 | 9.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.0 | 19.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 10.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.7 | 13.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 8.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.7 | 57.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.6 | 11.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 21.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 6.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.6 | 2.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.6 | 4.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 8.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 6.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 11.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 13.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 3.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 11.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 6.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 13.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 12.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 14.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 4.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 7.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 20.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 5.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 13.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 6.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 3.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 5.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 4.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 3.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 22.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 4.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 34.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 10.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 6.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 12.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 2.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 3.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 3.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.4 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 1.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 4.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 5.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 2.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |